BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33683496)

  • 1. An enigmatic case of IgG4-related nephropathy and an updated review of the literature.
    Spatola L; Ravera F; Sghirlanzoni MC; Verdesca S; Menegotto A; Querques M; Camozzi ML; Colombo V; Minetti EE
    Clin Exp Med; 2021 Aug; 21(3):493-500. PubMed ID: 33683496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal involvement in IgG4-related disease.
    Boffa JJ; Esteve E; Buob D
    Presse Med; 2020 Apr; 49(1):104017. PubMed ID: 32234380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of intensive B cell depletion therapy in severe cases of IgG4-related disease with renal involvement.
    Quattrocchio G; Barreca A; Demarchi A; Fenoglio R; Ferro M; Del Vecchio G; Massara C; Rollino C; Sciascia S; Roccatello D
    Immunol Res; 2020 Dec; 68(6):340-352. PubMed ID: 33174125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The histological diagnosis of IgG4-related disease on small biopsies: challenges and pitfalls.
    Arora K; Rivera M; Ting DT; Deshpande V
    Histopathology; 2019 Apr; 74(5):688-698. PubMed ID: 30408214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG4-related nephropathy.
    Quattrocchio G; Roccatello D
    J Nephrol; 2016 Aug; 29(4):487-93. PubMed ID: 26972314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroperitoneal fibrosis. Steroid treatment response seems to depend on its association to IgG4 related disease.
    Soriano Rios A; Paredes H; Hernández-Calleros J; Uscanga-Domínguez L; Peláez-Luna M
    Med Hypotheses; 2019 Jan; 122():120-123. PubMed ID: 30593393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG4-related kidney disease: Pathogenesis, diagnosis, and treatment.
    Mbengue M; Goumri N; Niang A
    Clin Nephrol; 2021 Jun; 95(6):292-302. PubMed ID: 33860756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG4-related kidney disease (IgG4-RKD) with membranous nephropathy as its initial manifestation: report of one case and literature review.
    Zhang NN; Wang YY; Kong LX; Zou WZ; Dong B
    BMC Nephrol; 2019 Jul; 20(1):263. PubMed ID: 31311519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG
    Ng SH; Tay JS; Lai EL
    BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34031075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin G4-related kidney diseases: An updated review.
    Salvadori M; Tsalouchos A
    World J Nephrol; 2018 Jan; 7(1):29-40. PubMed ID: 29359118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab Maintenance Therapy Reduces Rate of Relapse of Pancreaticobiliary Immunoglobulin G4-related Disease.
    Majumder S; Mohapatra S; Lennon RJ; Piovezani Ramos G; Postier N; Gleeson FC; Levy MJ; Pearson RK; Petersen BT; Vege SS; Chari ST; Topazian MD; Witzig TE
    Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1947-1953. PubMed ID: 29526692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of complement system in patients with biopsy-proven immunoglobulin G4-related kidney disease.
    Wang R; He D; Zhao L; Liang S; Liang D; Xu F; Zhang M; Zhu X; Chen H; Xie H; Zeng C; Tang Z; Liu Z
    Hum Pathol; 2018 Nov; 81():220-228. PubMed ID: 30031099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse large B cell lymphoma in a preceding IgG4-related disease with kidney restricted lambda light chain expression: case report and literature review.
    Wang H; Su T; Kang L; Yang L; Wang S
    BMC Nephrol; 2020 Jul; 21(1):315. PubMed ID: 32727411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG4-related disease: a clinical perspective.
    Maritati F; Peyronel F; Vaglio A
    Rheumatology (Oxford); 2020 May; 59(Suppl 3):iii123-iii131. PubMed ID: 32348524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin G4-related retroperitoneal fibrosis.
    Angarola E; Valeo Chulvi M; Peuchot V; García Rivello H; Jauk F
    Medicina (B Aires); 2022; 82(1):91-98. PubMed ID: 35037866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin G4-related hepatobiliary disease.
    Lee HE; Zhang L
    Semin Diagn Pathol; 2019 Nov; 36(6):423-433. PubMed ID: 31358425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG4-related kidney disease: the effects of a Rituximab-based immunosuppressive therapy.
    Quattrocchio G; Barreca A; Demarchi A; Solfietti L; Beltrame G; Fenoglio R; Ferro M; Mesiano P; Murgia S; Del Vecchio G; Massara C; Rollino C; Roccatello D
    Oncotarget; 2018 Apr; 9(30):21337-21347. PubMed ID: 29765543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin G4-related Disease of the Genitourinary System: Spectrum of Imaging Findings and Clinical-Pathologic Features.
    Oh JW; Rha SE; Choi MH; Oh SN; Youn SY; Choi JI
    Radiographics; 2020; 40(5):1265-1283. PubMed ID: 32870766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of eosinophilia in IgG4-related disease.
    Ming B; Zhong J; Dong L
    Clin Exp Rheumatol; 2022 May; 40(5):1038-1044. PubMed ID: 34369362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients.
    Khosroshahi A; Carruthers MN; Deshpande V; Unizony S; Bloch DB; Stone JH
    Medicine (Baltimore); 2012 Jan; 91(1):57-66. PubMed ID: 22210556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.